HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

CAMDEN ASSET MANAGEMENT L P /CA's Holding History (CIK: 0000903944)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 12,423,000 Value ($000) $12,345 Avg Close — Range —
Q1 2025
Shares 32,423,000 Value ($000) $34,308 Avg Close — Range —
Q4 2024
Shares 32,423,000 Value ($000) $30,922 Avg Close — Range —
Q3 2024
Shares 41,323,000 Value ($000) $41,357 Avg Close — Range —
Q2 2024
Shares 74,673,000 Value ($000) $71,187 Avg Close — Range —
Q1 2024
Shares 77,673,000 Value ($000) $68,729 Avg Close — Range —
Q4 2023
Shares 83,223,000 Value ($000) $71,938 Avg Close — Range —
Q3 2023
Shares 77,223,000 Value ($000) $65,161 Avg Close — Range —
Q2 2023
Shares 77,523,000 Value ($000) $64,388 Avg Close — Range —
Q1 2023
Shares 47,123,000 Value ($000) $39,937 Avg Close — Range —
Q4 2022
Shares 57,961,000 Value ($000) $56,113 Avg Close — Range —
Q3 2022
Shares 64,461,000 Value ($000) $54,550 Avg Close — Range —
Q2 2022
Shares 70,849,000 Value ($000) $62,501 Avg Close — Range —
Q1 2022
Shares 70,849,000 Value ($000) $61,727 Avg Close — Range —